The biotech is starting up with partial rights to a drug that’s approved in multiple Asian countries and its executives see ...
Star hopes its drug, which is currently in late-stage testing, might prove a more convenient, longer-lasting alternative to ...
Walmsley, who helped push GSK to focus more exclusively on specialty medicines and oncology, will be succeeded by commercial ...
The deal hands Genmab a drug that showed the potential in earlier testing to extend survival in head and neck cancer when ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback